Target intelligence / Profile preview

Exoglucanase 1 (Cellobiohydrolase I) (Cel7A)

Target
Cel7A
Molecular classification
Enzyme, Glycosyl hydrolase, Exocellulase
01

Overview

Cel7A, also known as Exoglucanase 1 or Cellobiohydrolase I (CBH1), is a major cellulolytic enzyme primarily secreted by filamentous fungi such as Trichoderma reesei [1]. It belongs to the Glycosyl Hydrolase Family 7 (GH7) and plays a pivotal role in the natural carbon cycle by breaking down crystalline cellulose into cellobiose [2]. The enzyme's structure is modular, featuring a catalytic domain with a tunnel-shaped active site and a cellulose-binding module (CBM) that anchors the enzyme to its insoluble substrate [1, 3]. Cel7A is the workhorse of the industrial enzyme industry, being the most abundant component in commercial cellulase preparations used for the production of second-generation biofuels from plant biomass [4]. Although it is not a target for human clinical therapeutics, it is a significant target for protein engineering aimed at increasing its thermostability and catalytic efficiency to reduce the cost of renewable energy production [2, 4].

Other names
CBH1Cellobiohydrolase I1,4-beta-cellobiohydrolaseGlycosyl hydrolase family 7 memberExocellulase 1
02

Mechanism of action

No therapeutic drugs currently target this enzyme; however, its catalytic mechanism involves the processive hydrolysis of crystalline cellulose from the reducing end to release cellobiose [2, 3].

03

Biological functions

Cellulose degradationCarbohydrate metabolismHydrolysis of 1,4-beta-D-glycosidic linkages
04

Safety considerations

Occupational asthmaRespiratory sensitizationAllergic rhinitis in industrial workers

Beyond the preview

Go deeper on Exoglucanase 1 (Cellobiohydrolase I) (Cel7A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exoglucanase 1 (Cellobiohydrolase I) (Cel7A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call